propranolol has been researched along with mabuterol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Evans, AK; Leib, RD; Ogawa, G; Park, HH; Saw, NL; Shamloo, M; Singhal, K | 1 |
2 other study(ies) available for propranolol and mabuterol
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Age-related neuroinflammation and pathology in the locus coeruleus and hippocampus: beta-adrenergic antagonists exacerbate impairment of learning and memory in aged mice.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Aging; Animals; Clenbuterol; Cognitive Dysfunction; Hippocampus; Inflammation Mediators; Learning; Locus Coeruleus; Male; Memory; Mice, Inbred C57BL; Neuroinflammatory Diseases; Propranolol; Receptors, N-Methyl-D-Aspartate | 2021 |